Stocks · Health care · Biological Products, (No Diagnostic Substances)

BIOCRYST PHARMACEUTICALS INC

BCRX Clue Score70
United States Fiscal year ends December CIK 0000882796 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Alane P Barnes
22 Dec 2025
Chief Legal Officer
Sold on a plan
21,773
$7.65
$166.56K
Alane P Barnes
15 Dec 2025
Chief Legal Officer
Sold on a plan
21,210
$7.65
$162.26K
Alane P Barnes
3 Dec 2025
Chief Legal Officer
Sold on a plan
19,770
$7.65
$151.24K
Alane P Barnes
2 Dec 2025
Chief Legal Officer
Sold on a plan
50,906
$7.21
$367.22K
Machelle Sanders
13 Nov 2025
Director
Sold on a plan
9,600
$7.14
$68.54K

What was left out

Form 4 filings counted 45
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 4
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,302,758
History held since 3 Nov 2006